Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients

NCT04852796 is registered in ClinicalTrials.gov with Centre Hospitalier de Cornouaille as lead sponsor.

NCT NCT04852796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
Lead sponsor
Centre Hospitalier de Cornouaille
Phase
Observational
Overall status
Completed
Start date
April 1, 2021
Completion date
April 1, 2023
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, hematologic malignancy, vaccine response impaired